Unit III – Gaddapotharam Manufacturing Facility

Overview

Neuland acquired a manufacturing facility (intermediate/API), Unit III, at Gaddapotharam industrial area near Hyderabad in December 2017. The facility is spread across approx. 12 acres and was inspected by the USFDA in 2015.

This manufacturing site is a multi-product facility and has five production blocks for advance intermediate and API manufacturing. It also has capabilities for on-site development, analytical method development, quality control laboratory and a pilot plant. Unit III was acquired and is designed to offer the much-needed flexibility to Neuland’s operations in the near term and more importantly to meet the growth aspirations of the company.

Highlights of Unit III

The facility is spread across approx. 12 acres
It has a capacity of about 305 KL
Recent successful ANVISA inspection has been done in February, 2022
It was inspected by the USFDA in 2015
It is a multi-product facility and has five production blocks for advanced intermediates and API manufacturing
There is a civil structure for a sixth block as well additional space available for expansion

Services

Enzymatic Reaction
Cyanation
Phosgenation
Oxidation
Reduction
Halogenation
Condensation
Sodamide Reaction
Sodium Hydride Reaction
Bromination
Esterification
Grignard Reaction

Capabilities

Block	Capabilities
Block – I	Two Production Lines with Pharma Area
Block – II	Intermediates Block
Block – III	Pilot Plant
Block – IV	Equipment for handling Sodium Cyanide Reactions Handles enzymes for Biocatalytic Reactions Fitted with PH Stats and Dosing Equipment
Block – V	Large block with RCVD – currently on intermediate Civil structure for large pharma area
Block – VI	Large civil structure